Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000233085 | SCV000287542 | benign | Colorectal cancer, susceptibility to, 10 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697259 | SCV000530364 | likely benign | not provided | 2021-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568535 | SCV000670995 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV001818599 | SCV002068139 | likely benign | not specified | 2019-04-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955330 | SCV004772190 | likely benign | POLD1-related condition | 2019-12-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |